Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedergoogle.com
Google Alert - HER2-ADC
Get the latest updates from Google Alert - HER2-ADC directly as they happen.
Follow now 124 followers
Latest posts
Last updated about 4 hours ago
Advancing Precision Medicine in HER2 (ERBB2)-Mutant Non-small Cell Lung Cancer - EMJ
about 5 hours ago
... HER2-directed antibody–drug conjugates (ADC; Cohort 5).10 The study also enrolled treatment-naive...
Key Considerations When Choosing an ADC in HR+/HER2– Breast Cancer | Docwire News
about 6 hours ago
Dr. Abirami Sivapiragasam reviews key ADC trials and sequencing strategies in metastatic...
Alphamab to Launch Phase III Trial of ADC in HER2-Positive Colorectal Cancer
about 7 hours ago
NEW YORK – China's regulatory officials have approved Alphamab Oncology's plans for...
Alphamab Oncology Announces Biparatopic HER2-targeting ADC JSKN003 Received ...
about 23 hours ago
PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the biparatopic HER2-targeting...
SKB264 showcased multiple data, ESMO 2L lung cancer approved for domestic listing
2 days ago
... HER2-BC patients. HER2 ADC A166 Selected oral report from a clinical...
Whitehawk Therapeutics Presents Real-World Analysis Confirming PTK7 as a Broadly ...
3 days ago
PTK7 is the third most highly expressed tumor marker among clinically validated...
Whitehawk Shows PTK7 in 70% of Solid Tumors, 3rd-Highest | WHWK Stock News
3 days ago
... ADC target after HER2 and HER3. Highest median PTK7 mRNA levels...
Whitehawk Therapeutics presents data on PTK7 as cancer drug target - StreetInsider
3 days ago
... (ADC) targets, following HER2 and HER3. The research showed PTK7 expression...
ADC internalization assays and pH-sensitive dye detection - News-Medical
3 days ago
Anti-Her2 Abs and Human IgG1 isotype ...
Breast Cancer Research: ESMO 2025 Shows Promising Results - Born2Invest
4 days ago
Ribociclib and abemaciclib consolidate their role in the management of HR+/HER2- breast...
Alphamab Oncology Announces the First Patient Dosed in a Phase I Clinical Study of PD-L1 ...
4 days ago
Biparatopic HER2-targeting ADC JSKN003 Was Granted Another Breakthrough Therapy Designation for HER2-Positive...
ESMO 25: OS/PFS Win For RemeGen's Disitamab Vedotin/Toripalimab Combo In 1L ...
4 days ago
... HER2-positive advanced urothelial carcinoma regardless of ... The combination of the...